Figure 1.
Dynamics of the total annual number of calendar days on sick leave during 2001–2019 and the average annual growth rates for indicators of SA in RA patients before and after the introduction of the biorx.si registry.
Figure 2.
Dynamics of the total annual number of calendar days on sick leave during 2001–2019 and the average annual growth rates for indicators of SA in PsA patients before and after the introduction of the biorx.si registry.
Figure 3.
Dynamics of the total annual number of calendar days on sick leave during 2001–2019 and the average annual growth rates for indicators of SA in AS patients before and after the introduction of the biorx.si registry.
Table 1.
Average annual growth rates of SA indicators for RA, PsA and AS by sex during two subperiods.
| AVERAGE ANNUAL GROWTH RATES (%) | Calendar days | Patients | Mean days per patient | Mean episodes per patient | Mean days per episode | |
|---|---|---|---|---|---|---|
| 2001–2007 | ||||||
| RA | ||||||
| Total | 1.199 | −0.938 | 2.394 | −1.317 | 3.505 | |
| Men | −1.894 | −3.048 | 1.643 | −1.322 | 2.537 | |
| Women | 2.485 | −0.049 | 2.790 | −1.313 | 3.889 | |
| M05 | ||||||
| Total | 2.735 | 1.741 | 1.617 | 1.744 | 0.741 | |
| Men | 4.160 | 2.731 | 1.613 | 4.707 | −3.271 | |
| Women | 1.725 | 1.376 | 1.247 | −1.218 | 1.574 | |
| M06 | ||||||
| Total | 0.534 | −1.997 | 2.917 | −2.458 | 4.722 | |
| Men | −4.746 | −5.117 | 1.114 | −3.457 | 3.922 | |
| Women | 2.811 | −0.607 | 3.718 | −1.458 | 4.958 | |
| 2008–2019 | ||||||
| RA | ||||||
| Total | −3.294 | −0.907 | −2.527 | 1.723 | −4.461 | |
| Men | −6.184 | −3.729 | −2.469 | 0.984 | −3.503 | |
| Women | −2.416 | 0.121 | −2.743 | 2.462 | −4.905 | |
| M05 | ||||||
| Total | −0.049 | 3.714 | −3.926 | 2.276 | −6.162 | |
| Men | −4.474 | −0.312 | −3.805 | 1.644 | −5.737 | |
| Women | 1.527 | 4.944 | −3.800 | 2.909 | −6.030 | |
| M06 | ||||||
| Total | −5.585 | −3.647 | −1.999 | 1.022 | −3.316 | |
| Men | −7.427 | −5.538 | −2.053 | 0.413 | −2.404 | |
| Women | −5.178 | −2.853 | −2.349 | 1.631 | −3.973 | |
| 2001–2010 | ||||||
| PsA | ||||||
| Total | 1.980 | 1.273 | 2.397 | −3.494 | 4.600 | |
| Men | 1.179 | 0.037 | 3.824 | −4.940 | 6.263 | |
| Women | 3.256 | 2.912 | 0.554 | −2.050 | 2.410 | |
| AS | ||||||
| Total | 4.476 | 0.704 | 5.395 | −2.218 | 6.064 | |
| Men | 2.654 | 0.067 | 3.742 | −2.065 | 4.726 | |
| Women | 9.351 | 2.306 | 8.599 | −2.372 | 9.452 | |
| 2011–2019 | ||||||
| PsA | ||||||
| Total | 0.397 | 0.729 | 0.770 | 0.247 | −0.628 | |
| Men | −8.155 | −3.651 | −3.055 | −1.072 | −3.648 | |
| Women | 7.963 | 4.798 | 3.527 | 1.565 | 1.420 | |
| AS | ||||||
| Total | 8.725 | 8.637 | 0.270 | 0.786 | −0.426 | |
| Men | 7.662 | 6.159 | 1.867 | −0.395 | 1.817 | |
| Women | 10.094 | 11.932 | −1.881 | 1.967 | −3.462 | |